KR100486316B1 - New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one - Google Patents

New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one Download PDF

Info

Publication number
KR100486316B1
KR100486316B1 KR10-2002-0039110A KR20020039110A KR100486316B1 KR 100486316 B1 KR100486316 B1 KR 100486316B1 KR 20020039110 A KR20020039110 A KR 20020039110A KR 100486316 B1 KR100486316 B1 KR 100486316B1
Authority
KR
South Korea
Prior art keywords
compound
formula
dihydro
dibenz
reaction
Prior art date
Application number
KR10-2002-0039110A
Other languages
Korean (ko)
Other versions
KR20040004890A (en
Inventor
서명원
Original Assignee
일동제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일동제약주식회사 filed Critical 일동제약주식회사
Priority to KR10-2002-0039110A priority Critical patent/KR100486316B1/en
Publication of KR20040004890A publication Critical patent/KR20040004890A/en
Application granted granted Critical
Publication of KR100486316B1 publication Critical patent/KR100486316B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H7/00Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for
    • A61H7/007Kneading
    • A61H7/008Suction kneading
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/08Arrangements or circuits for monitoring, protecting, controlling or indicating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes

Abstract

본 발명은 다음 구조식 (VI)의 화합물을 반응 촉매로 알루미늄 클로라이드를 사용하고, 불활성 용매중에서 프리델-크라프트 알킬화반응을 시키는 것으로 이루어진 다음 구조식 (I)의 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온의 신규 제조방법을 제공한다.The present invention provides a 5,11-dihydro-6H-dibenz of the following structural formula (I) consisting of using a compound of the following structural formula (VI) as a reaction catalyst and using Friedel-Craft alkylation in an inert solvent. b, e] new process for preparing azepine-6-one.

본 발명에 따라 제조된 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온은 항히스타민제를 비롯한 의약품 제조에 유용한 중간체 화합물이다.5,11-dihydro-6H-dibenz [b, e] azin-6-ones prepared according to the present invention are useful intermediate compounds for the manufacture of pharmaceuticals, including antihistamines.

Description

5,11-디히드로-6에이치-디벤즈[비,이]아제핀-6-온의 새로운 제조방법 {New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one}New preparation method of 5,11-dihydro-6H-dibenz [b, e] azepin-6- one}

본 발명은 의약품등의 제조에 사용되는 다음 구조식 (I)의 화합물인 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온 (또는 5,6-디히드로-6-옥소모판트리딘)을 제조하는 신규 방법에 관한 것이다.The present invention provides 5,11-dihydro-6H-dibenz [b, e] azin-6-one (or 5,6-dihydro-6) which is a compound of formula (I) -Oxomopantridine).

[화학식 1][Formula 1]

상기 구조식 (I)의 화합물은 항히스타민제인 3-아미노-9,13b-디히드로-1H-디벤즈[c,f]이미다조[1,5-a]아제핀 히드로클로라이드를 비롯한 각종 의약품 합성을 위한 중간체로 유용하게 사용된다. 이에, 상기 구조식 (I)의 화합물의 제조방법에 대한 다양한 연구가 진행되어 왔다.The compound of formula (I) is used for the synthesis of various pharmaceuticals, including the antihistamine 3-amino-9,13b-dihydro-1H-dibenz [c, f] imidazo [1,5-a] azepine hydrochloride. It is useful as an intermediate. Accordingly, various studies on the preparation method of the compound of formula (I) have been conducted.

상기 구조식 (I)의 화합물의 일반적인 제조방법은 Indian J. Chem. 23B, 165(1984), 독일특허 제2431409호, 미국특허 제3367930호, 독일특허 제2505714호 및 미국특허 제3910890호 등에 기술되어 있다. 이들 공지의 제조방법에 기술된 구조식 (I)의 대표적인 제조방법은 다음과 같이 세 가지로 나눌 수 있다.A general method for preparing the compound of formula (I) is Indian J. Chem. 23B, 165 (1984), German Patent No. 2431409, US Patent No. 3367930, German Patent No. 2505714, US Patent No. 3910890, and the like. Representative production methods of formula (I) described in these known production methods can be divided into three types as follows.

첫 번째, 구조식 (II)의 화합물을 베크만 전위반응시켜 목적화합물 (I)의 화합물을 제조하는 방법과First, the method of preparing the compound of the target compound (I) by Beckman potential reaction of the compound of the formula (II) and

[반응식 1]Scheme 1

두 번째, 구조식 (III)의 화합물을 포스겐과 반응하여 구조식 (IV)를 제조한 후 알루미늄 클로라이드를 촉매로 사용하여 목적화합물 (I)을 제조하는 방법과 Secondly, to prepare the desired compound (I) by reacting the compound of formula (III) with phosgene to produce formula (IV) and then using aluminum chloride as a catalyst;

[반응식 2]Scheme 2

세 번째, 구조식 (V)의 화합물을 벤젠 용매하에서 불산 또는 알류미늄클로라이드와 반응시켜 목적화합물 (I)을 제조하는 방법이 공지되어있다.Third, a method for preparing the desired compound (I) by reacting the compound of formula (V) with hydrofluoric acid or aluminum chloride in a benzene solvent is known.

[반응식 3]Scheme 3

그러나 이들 방법 중 첫번째 방법인 베크만 전위반응을 이용한 구조식 (II)의 화합물로부터 목적화합물 (I)의 합성은 실제로는 거의 일어나지 않는다. However, the synthesis of the target compound (I) from the compound of the formula (II) using the Beckman potential reaction, which is the first of these methods, hardly occurs.

또한 두 번째 방법인 구조식 (III)의 화합물로부터 구조식 (IV)를 제조하는 방법은 강한 독성을 가진 화합물인 포스겐을 사용하여야만 하므로 매우 위험한 공정이다. 또한 출발물질로 사용되는 화합물 (III)는 여러 단계의 공정을 거쳐 제조해야만 하는 난점이 있다. In addition, the second method of preparing the formula (IV) from the compound of the formula (III) is a very dangerous process because it requires the use of phosgene, a compound with strong toxicity. In addition, compound (III), which is used as a starting material, has to be prepared through a multi-step process.

세번째로 구조식 (V)의 화합물로부터 구조식 (I)의 화합물을 제조하는 방법 역시 출발물질인 구조식 (V)의 화합물은 독성이 강한 포스겐을 사용하여 제조해야 하며, 반응에 있어서도 독성이 강한 벤젠을 용매로 사용하고, 부식성이 강한 불산을 사용하는 등 여러 가지 단점을 가지고 있다.Third, the method for preparing the compound of formula (I) from the compound of formula (V) should also be prepared using the toxic phosgene, which is also a starting material, and the solvent of benzene which is highly toxic in the reaction. It has a number of disadvantages, such as the use of hydrofluoric acid, and the use of hydrofluoric acid.

본 발명에서는 목적 화합물을 합성하는데 있어 공지방법의 단점인 낮은 수율과 독성 및 부식성이 강한 화합물의 사용 등의 여러 가지 문제점을 해결하고 온화하고 용이한 반응조건에서 높은 수율로 목적화합물을 제조하는 방법을 제공하는데 그 목적이 있다. In the present invention, a method for preparing a target compound in high yield under mild and easy reaction conditions and solving various problems such as the use of a compound having a low yield and a toxic and corrosive compound, which are disadvantages of known methods in synthesizing the target compound, are provided. The purpose is to provide.

본 발명은 o-클로로메틸벤조산클로라이드와 아닐린과의 축합반응을 통하여 얻은 화합물 (VI)를 출발물질로 하여 분자내 프리델-크라프트 알킬화 반응을 통하여 목적 화합물 (I)을 제조하는 것을 특징으로 한다.The present invention is characterized in that the desired compound (I) is prepared through intramolecular Friedel-Craft alkylation reaction using compound (VI) obtained through condensation reaction of o-chloromethylbenzoic acid chloride with aniline as a starting material.

본 발명을 보다 구체적으로 설명하면 다음과 같다.The present invention will be described in more detail as follows.

본 발명은 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 제조하는데 있어 [반응식 4]에 나타낸 바와 같이 o-클로로메틸벤조산클로라이드와 아닐린과의 축합반응을 통해 얻어진 구조식 (VI)의 화합물을 출발물질로 사용하여 프리델-크라프트 알킬화반응을 통해 목적화합물 (I)을 얻을 수 있다. The present invention provides a condensation reaction of o-chloromethylbenzoic acid chloride with aniline as shown in [Scheme 4] in preparing 5,11-dihydro-6H-dibenz [b, e] azin-6-one. The target compound (I) can be obtained through Friedel-Crafts alkylation using the compound of formula (VI) obtained as a starting material.

여기에서 o-클로로메틸벤조산클로라이드는 농약품 및 의약품의 중간체로 널리 사용되고 있는 공지의 화합물로 공지의 합성방법 [J. Org. Chem. 40, 21, 3026(1975) 및 WO 0142185호 등]을 이용하여 손쉽게 얻을 수 있다.Here, o-chloromethylbenzoic acid chloride is a well-known compound widely used as an intermediate of agrochemicals and pharmaceuticals. Org. Chem. 40, 21, 3026 (1975) and WO 0142185 et al.

본 반응에서 프리델-크라프트 반응의 촉매로는 알루미늄 클로라이드을 사용하였으며, 이의 당량은 구조식 (VI)의 화합물을 기준으로 1.0 내지 10.0 당량을 사용하였으며 바람직하게는 2.0 당량 전후이다. 반응온도는 상온 내지 사용된 용매의 환류온도이고, 바람직하게는 90℃에서 110℃정도이다. 반응용매로는 메틸렌클로라이드, 클로로포름, 사염화탄소 등의 염소함유 탄화수소류와 니트로벤젠, 니트로에탄, 니트로메탄 등의 니트로화 알칸류 등의 용매를 사용하고 바람직하게는 니트로메탄과 니트로벤젠을 사용한다. 반응 시간은 1시간에서 24시간, 바람직하게는 5시간에서 6시간 정도이다.In the present reaction, aluminum chloride was used as a catalyst for the Friedel-Craft reaction, and an equivalent thereof was used in an amount of 1.0 to 10.0 equivalents based on the compound of formula (VI), and preferably around 2.0 equivalents. The reaction temperature is from room temperature to the reflux temperature of the solvent used, preferably from 90 ° C to 110 ° C. As the reaction solvent, solvents such as chlorine-containing hydrocarbons such as methylene chloride, chloroform and carbon tetrachloride and nitrated alkanes such as nitrobenzene, nitroethane and nitromethane are used, and preferably nitromethane and nitrobenzene are used. The reaction time is about 1 hour to 24 hours, preferably about 5 hours to 6 hours.

[반응식 4]Scheme 4

이하 본 발명을 다음의 실시예에 의거하여 더욱 상세히 설명하는 바, 본 발명이 이들 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, which should not be construed as limiting the invention thereto.

[참고 실시예 1]Reference Example 1

α-클로로-o-톨루아닐리드의 합성Synthesis of α-chloro-o-toluanilide

6.27ml(68.8mmol)의 아닐린, 5.85ml(72.3mmol)의 피리딘 혼합물에 50ml의 톨루엔을 가하여 용해시키고, 반응 혼합물을 0℃로 냉각시켰다. 13.0g(68.8mmol)의 o-클로로메틸벤조산클로라이드를 20ml의 톨루엔에 녹인 용액을 반응용액에 10℃이하의 온도를 유지하면서 적가하고, 실온에서 1시간동안 교반하면서 반응시켰다. 20ml의 물을 반응액에 가하고 실온에서 1시간동안 추가 교반 후, 생성된 결정성 화합물을 여과하여 흰색의 목적화합물을 얻었다. 한편, 여액의 톨루엔층을 분리하여 1N 염산 수용액과 물로 세척 후 건조, 농축하여 목적화합물을 얻었다. 얻어진 목적화합물을 16.3g의 수율(이론치의 96%)로 수득하였다.50 ml of toluene was dissolved in 6.27 ml (68.8 mmol) of aniline and 5.85 ml (72.3 mmol) of pyridine mixture, and the reaction mixture was cooled to 0 ° C. A solution obtained by dissolving 13.0 g (68.8 mmol) of o-chloromethylbenzoic acid chloride in 20 ml of toluene was added dropwise to the reaction solution while maintaining the temperature below 10 ° C, and reacted with stirring at room temperature for 1 hour. 20 ml of water was added to the reaction solution, and after further stirring at room temperature for 1 hour, the resulting crystalline compound was filtered to obtain a white target compound. On the other hand, the toluene layer of the filtrate was separated, washed with 1N aqueous hydrochloric acid solution and water, dried and concentrated to obtain the target compound. The desired compound obtained was obtained in a yield of 16.3 g (96% of theory).

융점 : 119.5~120℃ Melting Point: 119.5 ~ 120 ℃

IR cm-1(KBr) : 3270, 3130, 3080, 1640, 1590, 1540, 1490, 1430, 1325, 1265IR cm -1 (KBr): 3270, 3130, 3080, 1640, 1590, 1540, 1490, 1430, 1325, 1265

1H-NMR(CDCl3) : δ(ppm) 4.84(s, 2H), 7.15(t, 1H, J=7.5Hz), 7.34~7.65(m, 9H), 7.89(br, 1H) 1 H-NMR (CDCl 3 ): δ (ppm) 4.84 (s, 2H), 7.15 (t, 1H, J = 7.5 Hz), 7.34-7.75 (m, 9H), 7.89 (br, 1H)

MASS m/z : 245 (M+)MASS m / z: 245 (M +)

[참고 실시예 2]Reference Example 2

20g(146mmol)의 프탈라이드, 0.27g(4.4mmol)의 붕산, 1.22g(4.4mmol)의 트리페닐포스핀옥사이드의 혼합물을 가열 용해시킨 후, 13.9ml(190mmol)의 티오닐클로라이드를 약 130℃의 온도에서 적가하고, 동일 온도에서 5시간동안 교반하였다. 반응 혼합물에 10ml의 톨루엔을 첨가 후 농축하고, 이 농축액을 50ml의 톨루엔에 녹여 13.3ml(146mmol)의 아닐린, 13ml(161mmol)의 피리딘, 220ml의 톨루엔의 혼합 용액에 10℃이하의 온도에서 적가 후, 실온에서 1시간동안 교반하면서 반응시켰다.After dissolving a mixture of 20 g (146 mmol) of phthalide, 0.27 g (4.4 mmol) of boric acid and 1.22 g (4.4 mmol) of triphenylphosphine oxide, 13.9 ml (190 mmol) of thionyl chloride was heated to about 130 ° C. It was added dropwise at the temperature of and stirred for 5 hours at the same temperature. 10 ml of toluene was added to the reaction mixture, followed by concentration. The concentrated solution was dissolved in 50 ml of toluene, and added dropwise to a mixed solution of 13.3 ml (146 mmol) of aniline, 13 ml (161 mmol) of pyridine, and 220 ml of toluene at a temperature of 10 ° C. or lower. The reaction was stirred at room temperature for 1 hour.

반응 용액에 30ml의 물을 가하고 실온에서 1시간동안 추가 교반 후, 생성된 결정성 화합물을 여과하여 흰색의 목적화합물 27.6g을 수득하였다(이론치의 77%).30 ml of water was added to the reaction solution, followed by further stirring at room temperature for 1 hour, and the resulting crystalline compound was filtered to give 27.6 g of a white desired compound (77% of theory).

[실시예 1]Example 1

5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온의 합성Synthesis of 5,11-dihydro-6H-dibenz [b, e] azin-6-one

8.36g(62.7mmol)의 알루미늄 클로라이드를 70ml의 니트로메탄에 녹인 후 7.0g(28.5mmol)의 α-클로로-o-톨루아닐리드를 넣고 6시간동안 환류교반하였다. 실온까지 방냉 후 얼음과 염산의 혼합물에 반응 혼합물을 붓고 교반 후, 유기층을 분리하였다. 분리한 유기층을 물로 세척 후 건조, 농축하여 얻은 물질을 30ml의 톨루엔에서 재결정하여 4.3g의 수율(이론치의 71%)로 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 수득하였다.After dissolving 8.36 g (62.7 mmol) of aluminum chloride in 70 ml of nitromethane, 7.0 g (28.5 mmol) of α-chloro-o-toluanilide was added and stirred under reflux for 6 hours. After cooling to room temperature, the reaction mixture was poured into a mixture of ice and hydrochloric acid, and stirred, and then the organic layer was separated. The separated organic layer was washed with water, dried and concentrated. The obtained material was recrystallized from 30 ml of toluene to yield 5,11-dihydro-6H-dibenz [b, e] azepine- in 4.3 g yield (71% of theory). 6-one was obtained.

융점 : 200~201℃ Melting Point: 200 ~ 201 ℃

IR cm-1(KBr) : 3190, 3030, 2980, 2910, 1650, 1590, 1570, 1490, 1450, 1440, 1380IR cm -1 (KBr): 3190, 3030, 2980, 2910, 1650, 1590, 1570, 1490, 1450, 1440, 1380

1H-NMR(CDCl3) : δ 3.87(s, 2H), 7.00~7.27(m, 6H), 7.37(t, 1H, J=7.5Hz), 7.86(d, 1H, J=7.7Hz) 1 H-NMR (CDCl 3 ): δ 3.87 (s, 2H), 7.00 ~ 7.27 (m, 6H), 7.37 (t, 1H, J = 7.5Hz), 7.86 (d, 1H, J = 7.7Hz)

MASS m/z : 209 (M+)MASS m / z: 209 (M +)

[실시예 2]Example 2

2.18g(16.3mmol)의 알루미늄 클로라이드를 5ml의 니트로벤젠에 녹인 후 2.0g(8.1mmol)의 α-클로로-o-톨루아닐리드를 넣고 밤새 환류 교반하였다. 실온까지 방냉 후 얼음과 염산의 혼합물에 반응 혼합물을 붓고 교반 후, 유기층을 분리하였다. 분리한 유기층을 물로 세척 후 건조, 농축하여 얻은 물질을 칼럼 크로마토그래피로 분리하여 0.6g의 수율(이론치의 45%)로 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 수득하였다.After dissolving 2.18 g (16.3 mmol) of aluminum chloride in 5 ml of nitrobenzene, 2.0 g (8.1 mmol) of α-chloro-o-toluanilide was added and stirred under reflux overnight. After cooling to room temperature, the reaction mixture was poured into a mixture of ice and hydrochloric acid, and stirred, and then the organic layer was separated. The separated organic layer was washed with water, dried and concentrated, and the obtained material was separated by column chromatography, yielding 0.6 g (45% of theory) of 5,11-dihydro-6H-dibenz [b, e] azepine- 6-one was obtained.

본 발명에 따른 제조방법은 촉매로서 독성 및 부식성이 적은 알루미늄 클로라이드를 사용하고 온화한 반응조건에서 반응을 수행하여 높은 수율로 목적화합물 및 유사 화합물을 제조하는 방법을 제공한다.The production method according to the present invention provides a method for producing the target compound and the similar compound in high yield by using aluminum chloride having low toxicity and corrosion resistance as a catalyst and carrying out the reaction under mild reaction conditions.

Claims (3)

다음 화학식 2로 표시되는 화합물을 분자내 프리델-크라프트 알킬화반응을 통하여 화학식 1로 표시되는 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 제조하는 방법.Next, a method of preparing 5,11-dihydro-6H-dibenz [b, e] azin-6-one represented by Formula 1 through an intramolecular Friedel-Craft alkylation reaction of the compound represented by Formula 2; [화학식 1][Formula 1] [화학식 2][Formula 2] 제 1항에 있어서, 반응촉매로 알루미늄 클로라이드를 사용하는 것을 특징으로 하는 화학식 1의 화합물을 제조하는 방법.The method of claim 1, wherein aluminum chloride is used as the reaction catalyst. 제 1항에 있어서, 반응용매로 니트로메탄, 니트로에탄, 니트로벤젠, 클로로포름, 메틸렌클로라이드, 사염화탄소 및 1,2-디클로로벤젠에서 선택된 용매를 사용하는 방법.The process according to claim 1, wherein a solvent selected from nitromethane, nitroethane, nitrobenzene, chloroform, methylene chloride, carbon tetrachloride and 1,2-dichlorobenzene is used as the reaction solvent.
KR10-2002-0039110A 2002-07-06 2002-07-06 New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one KR100486316B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2002-0039110A KR100486316B1 (en) 2002-07-06 2002-07-06 New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0039110A KR100486316B1 (en) 2002-07-06 2002-07-06 New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one

Publications (2)

Publication Number Publication Date
KR20040004890A KR20040004890A (en) 2004-01-16
KR100486316B1 true KR100486316B1 (en) 2005-04-29

Family

ID=37315282

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0039110A KR100486316B1 (en) 2002-07-06 2002-07-06 New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one

Country Status (1)

Country Link
KR (1) KR100486316B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113072500B (en) * 2021-04-07 2023-01-20 淮北师范大学 Synthetic method of dibenzo [ b, e ] azepine compound

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326526A1 (en) * 1988-01-25 1989-08-02 ISTITUTO DE ANGELI S.p.A. Aminoketones of substituted dibenzo- and pyridobenzo-azepinones and pharmaceutical compositions
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
WO1999007380A1 (en) * 1997-08-11 1999-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e] AZEPIN-6-ONES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
US6201120B1 (en) * 1997-11-20 2001-03-13 Pharm-Eco Laboratories, Inc. Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326526A1 (en) * 1988-01-25 1989-08-02 ISTITUTO DE ANGELI S.p.A. Aminoketones of substituted dibenzo- and pyridobenzo-azepinones and pharmaceutical compositions
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
WO1999007380A1 (en) * 1997-08-11 1999-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e] AZEPIN-6-ONES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
US6201120B1 (en) * 1997-11-20 2001-03-13 Pharm-Eco Laboratories, Inc. Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines

Also Published As

Publication number Publication date
KR20040004890A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
WO2007140989A2 (en) Process for the manufacture of 2-butyl-3- (4-methoxybenzoyl) -5-nitrobenzofurane and use thereof in the production of of medicaments
JP6987930B2 (en) Method for producing 1- (3,5-dichlorophenyl) -2,2,2-trifluoro-etanone and its derivative
JP2964041B2 (en) Novel process for producing phenyl-1-diethylaminocarbonyl-1-phthalimidomethyl-2-cyclopropane Z
US4145364A (en) Preparation of fluorinated anilines
KR100486316B1 (en) New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
KR20180116371A (en) Process for producing 4-alkoxy-3-hydroxypicolic acid
JPH05262734A (en) Production of 5-substituted 2-chloropyridines
US6046351A (en) Process for preparing racemic phenethylamines
US6559291B1 (en) Process for the preparation of diazonaphthoquinonesulfonylchlorides using diphosgene and triphosgene
Oliver et al. Nitration of two TCDD's and their conversion to 1, 2, 3, 6, 7, 8-HCDD
KR20030017473A (en) One-pot synthesis of alkyl 3-cyclopropylamino-2-[2,4-dibromo-3-(difluoromethoxy)benzoyl]-2-propenoate as a useful intermediate for antibacterial quinolone medicaments
JP4127867B2 (en) N-substituted cis-N-propenyl-acetamide and process for producing the same
PL130528B1 (en) Process for preparing n-/halomethyl/-acylamides
EP0294615B1 (en) Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists
JPH0794420B2 (en) Process for producing substituted phenoxyacetaldehyde oximes
KR0163206B1 (en) Process for producing an aromatic compound by electrophilic reaction and aromatic compound derivatives
JPH082842B2 (en) Fluorodinitrobenzene derivative and method for producing the same
JP3903291B2 (en) Process for producing 2,3,6,7,10,11-hexaalkoxytriphenylenes
JP3431218B2 (en) Preparation of chromancarboxylic acid derivatives
JP3646223B2 (en) Method for producing aromatic compound by electrophilic reaction and aromatic compound
JP6998937B2 (en) A method for producing a 4-substituted 2,3-dihydro-1-benzofuran derivative by cyclizing a 2- (2-diazonium-6-substituted phenyl) ethanol salt.
JPH0140833B2 (en)
KR100486320B1 (en) Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
US4615842A (en) Method for making ethynylated aromatic compounds and a method for making nitronium trifluoromethanesulfonate
JPS6256149B2 (en)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee